SOURCE Koya Medical

DALLAS and NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 1:50 pm ET at the Lotte New York Palace.

Andy Doraiswamy (CEO) and Damian Rippole (CFO) will highlight the company's ongoing clinical research, provide updates on commercial momentum for its portfolio-including Dayspring® non-pneumatic compression treatment for chronic edema-and share progress on its vascular pipeline.

About Koya Medical

Founded in 2018 and headquartered in Dallas, Koya Medical is redefining vascular health with patient-centered solutions designed to support care from clinic to home. Inspired by a personal journey with vascular disease, Koya's mission is to close treatment gaps -starting with its FDA-cleared Dayspring treatment system and advancing its pipeline.

Why Vascular Health Matters

More than 35 million Americans live with venous and lymphatic diseases-serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health-highlighting the urgent need for modern, evidence-based, and scalable solutions.

Learn more at www.koyamedical.com and follow Koya on LinkedIn.

©PR Newswire. All Rights Reserved.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]